Vázquez-Quiroga, Sara
García-Martínez, Sofía
Jiménez-Meseguer, María
Irusta-Gonzalo, Ana
Jáñez-Carrera, Raquel
Otero-Espinar, Francisco Javier
Ruiz-Martín, Guadalupe
García-Díaz, Benito
López-Martín, Ana
Peña-Cabia, Silvia
Funding for this research was provided by:
Fundación Española Farmacia Hospitalaria
Fundación Universidad Alfonso X el Sabio
Article History
Received: 29 January 2026
Accepted: 1 April 2026
First Online: 7 April 2026
Declarations
:
: The study is conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice, as well as with all Spanish legislation applicable to observational studies (Royal Decree 957/2020, of 3 November). The study has received a favorable opinion from the Research Ethics Committee with Medicines of Severo Ochoa University Hospital, under code 1537-A (91/23).Patients who agree to participate are provided with an information sheet and sign a written informed consent form, of which they receive a copy. The treatment, processing, and transfer of personal data of all participating subjects will comply with the provisions of Organic Law 3/2018, of 5 December, on the Protection of Personal Data and Guarantee of Digital Rights.
: Not applicable.
: The authors declare no competing interests.